Respiratory syncytial virus vaccination among US adults aged ≥60 years

Respiratory syncytial virus vaccination among US adults aged ≥60 years

BackgroundRespiratory syncytial virus (RSV) vaccines have been recommended for US adults aged ≥60 years for nearly one year. However, the extent of vaccination coverage and the factors influencing uptake remain underexplored. This study aimed to evaluate national and state-specific RSV vaccination c...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaozhen Geng, Wenjun Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Immunology
Subjects:	respiratory syncytial virus RSV vaccine older adults socioeconomic
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1427550/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
by: Alexander Domnich, et al.
Published: (2025-01-01)

The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis
by: Daisuke Kurai, et al.
Published: (2024-12-01)

Epidemiology and clinical characteristics of hospitalized adults with respiratory syncytial virus infection at a medical center in northern Taiwan
by: Wen-Cheng Chang, et al.
Published: (2024-12-01)

Cost-effectiveness of bivalent respiratory syncytial virus prefusion F vaccine for prevention of respiratory syncytial virus among older adults in Germany
by: Ahuva Averin, et al.
Published: (2025-12-01)

Prevention of respiratory syncytial virus infection in children. Recommendations of the Polish Society of Paediatrics and the National Paediatric Consultant
by: Teresa Jackowska, et al.
Published: (2024-12-01)

The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease
by: Gengxin Zhang, et al.
Published: (2024-10-01)

Respiratory Syncytial Virus: What is the Risk Over 60?
by: Oğuzhan Acet, et al.
Published: (2024-12-01)

Role of bovine respiratory syncytial virus in etiology of respiratory diseases on milk farms
by: S. V. Koteneva, et al.
Published: (2021-03-01)

Immune Responses to Respiratory Syncytial Virus Vaccines: Advances and Challenges
by: Gabriela Souza da Silva, et al.
Published: (2024-11-01)

Cost-effectiveness analysis of respiratory syncytial virus vaccination with the adjuvanted prefusion F protein vaccine (RSVPreF3 OA) for adults ≥60 years old in Japan
by: Akiko Mizukami, et al.
Published: (2024-12-01)

Recommendation for the use of respiratory syncytial virus vaccines
by: Ping-Ing Lee, et al.
Published: (2025-02-01)

The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review
by: Roberto Debbag, et al.
Published: (2024-12-01)

Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Greece
by: George Gourzoulidis, et al.
Published: (2024-10-01)

Anti-Idiotypic Antibody as a Booster Vaccine Against Respiratory Syncytial Virus
by: Shreya Mukhopadhyay, et al.
Published: (2025-01-01)

News Media Reports of Respiratory Syncytial Virus in Canada and the United States During the 2022–2023 Respiratory Virus Season: A Cross‐Sectional Study
by: Sherilyn K. D. Houle, et al.
Published: (2024-11-01)

Impact of Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older in Spain
by: Sara Jimeno Ruiz, et al.
Published: (2024-11-01)

Respiratory Virus Vaccines: Pathways to Recommendations and Enhanced Coverage for At-Risk Populations
by: Stefania Maggi, et al.
Published: (2024-12-01)

Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico
by: José Luis Huerta, et al.
Published: (2025-01-01)

The Impact of Palivizumab for Respiratory Syncytial Virus Prophylaxis on Preschool Childhood Asthma
by: Hannah Ora Hasson, et al.
Published: (2024-11-01)

A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection
by: Angela Branche, et al.
Published: (2024-12-01)

Burden of Acute Respiratory Infections Caused by Influenza Virus, Respiratory Syncytial Virus, and SARS-CoV-2 with Consideration of Older Adults: A Narrative Review
by: William P. Hanage, et al.
Published: (2024-12-01)

Respiratory syncytial virus vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine
by: Tiago Alfaro, et al.
Published: (2025-12-01)

Foreword: Prevention of COVID-19, Influenza, and Respiratory Syncytial Virus in At-Risk Populations
by: Stefan Gravenstein
Published: (2024-12-01)

Impact of COVID-19 control measures on respiratory syncytial virus and hand-foot-and-mouth disease transmission in Hong Kong and South Korea
by: Yiu Chung Lau, et al.
Published: (2024-12-01)

Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults
by: Catherine A. Panozzo, et al.
Published: (2024-11-01)

Clinical manifestations, para-clinical features and outcome of Iranian adults with respiratory syncytial virus (RSV) infection: a report from hospitalized patients
by: Maryam Shafaati, et al.
Published: (2025-02-01)

Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options
by: Matteo Riccò, et al.
Published: (2024-11-01)

Circulation of Respiratory Syncytial Virus (RSV) in Poland Between Seasons of 2009/2010 and 2022/2023 Based on SENTINEL System
by: Karol Szymański, et al.
Published: (2025-01-01)

Comparative study on the epidemiological characteristics and hazards of respiratory syncytial virus and influenza virus infections among elderly people
by: Jiangtao Yu, et al.
Published: (2024-10-01)

Prevalence of Respiratory Syncytial Virus Infection in Hospitalized COPD Patients in Spain Between 2018–2022
by: Rosa María Gómez-García, et al.
Published: (2025-01-01)

Robust and Long-Lasting Immunity and Protection in Mice Induced by Lipopolyplex-Delivered mRNA Vaccines Expressing the Prefusion Protein of Respiratory Syncytial Virus
by: Xuchang Shan, et al.
Published: (2025-01-01)

The Role of Inflammation in the Pathogenesis of Viral Respiratory Infections
by: Arnaud John Kombe Kombe, et al.
Published: (2024-12-01)

RSV Vaccine with Nanoparticle-Based Poly-Sorbitol Transporter (PST) Adjuvant Improves Respiratory Protection Against RSV Through Inducing Both Systemic and Mucosal Humoral Immunity
by: Seong-Mook Jung, et al.
Published: (2024-11-01)

Circulation and Codetections of Influenza Virus, SARS-CoV-2, Respiratory Syncytial Virus, Rhinovirus, Adenovirus, Bocavirus, and Other Respiratory Viruses During 2022–2023 Season in Latvia
by: Inara Kampenusa, et al.
Published: (2024-10-01)

Bivalirudin exerts antiviral activity against respiratory syncytial virus-induced lung infections in neonatal mice
by: Zhuang Shihao, et al.
Published: (2022-09-01)

Hospital-Based Surveillance of Respiratory Viruses Among Children Under Five Years of Age with ARI and SARI in Eastern UP, India
by: Hirawati Deval, et al.
Published: (2024-12-01)

Optimization of cultivation parameters for bovine respiratory syncytial virus strain Vologda/2019
by: V. V. Kirpichenko, et al.
Published: (2020-09-01)

Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in Italy
by: Andrea Marcellusi, et al.
Published: (2025-01-01)

CULTURAL PROPERTIES OF BOVINE RESPIRATORY SYNCYTIAL VIRUS STRAIN AB1908
by: V. V. Kirpichenko, et al.
Published: (2019-12-01)

Burden of Respiratory Syncytial Virus Infection in Children and Older Patients Hospitalized with Asthma: A Seven-Year Longitudinal Population-Based Study in Spain
by: Rosa María Gomez-Garcia, et al.
Published: (2024-11-01)